Unlocking Treatment Strategies for Anaplastic Thyroid Cancer

episode

Cleveland Clinic Cancer Advances not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

"I'm afraid of my life to turn on the heat" 1h 8m · 22 Sep 2026 · Liveline

THE FALL RESET: become unrecognizable before 2027 16 min · 22 Sep 2026 · LYSS

Our Show's Effort Jumps Off The Tape | Local Hour 40 min · 22 Sep 2026 · The Dan Le Batard Show

“Southern Gothic" 57 min · 22 Sep 2026 · The Tony Kornheiser Show

A Bad Day For The Narrative | Episode 375 1h 3m · 22 Sep 2026 · VINCE

Turning Down a Movie Deal 49 min · 22 Sep 2026 · VIEWS with David Dobrik & Jason Nash

Report any issue

Source

Recorded15 Jun 2023

Publisherfeeds.buzzsprout.com

Handlerec:1648227

Show notes

Joseph Scharpf, MD, FACS, Director of Head and Neck Endocrine Surgery at the Cleveland Clinic Head and Neck Institute, and Emrullah Yilmaz, MD, PhD, an oncologist at Cleveland Clinic Taussig Cancer Institute, specializing in head and neck cancers, join the Cancer Advances podcast to discuss their study that provides insights to treatment strategies and tumor characteristics of anaplastic thyroid cancer. Listen as Dr. Scharpf and Dr. Yilmaz discuss patients with BRAF mutations and Cleveland Clinic's collaborative approach for thyroid cancer care.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in